199 related articles for article (PubMed ID: 2434219)
21. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.
Lambert LE; Paulnock DM
J Immunol; 1987 Oct; 139(8):2834-41. PubMed ID: 3116096
[TBL] [Abstract][Full Text] [Related]
22. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
23. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
[TBL] [Abstract][Full Text] [Related]
24. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
25. Selective augmentation by recombinant interferon-gamma of the intracellular content of S-adenosylmethionine in murine macrophages.
Bonvini E; Hoffman T; Herberman RB; Varesio L
J Immunol; 1986 Apr; 136(7):2596-604. PubMed ID: 3081646
[TBL] [Abstract][Full Text] [Related]
26. Macrophage antitumor activity: impaired responsiveness to interferon-gamma of macrophages from genetically defective mice.
Boraschi D; Censini S; Tagliabue A
Eur J Immunol; 1984 Nov; 14(11):1061-3. PubMed ID: 6437846
[TBL] [Abstract][Full Text] [Related]
27. [Mechanisms of macrophage activation and macrophage-mediated tumoricidal activity].
Kiyotaki C
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3386-91. PubMed ID: 2508564
[TBL] [Abstract][Full Text] [Related]
28. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
29. Analysis of deficiencies in IFN-gamma-mediated priming for tumor cytotoxicity in peritoneal macrophages from A/J mice.
Hamilton TA; Somers SD; Becton DL; Celada A; Schreiber RD; Adams DO
J Immunol; 1986 Nov; 137(10):3367-71. PubMed ID: 3095430
[TBL] [Abstract][Full Text] [Related]
30. [Herpes simplex virus and macrophages].
Scieux C
Pathol Biol (Paris); 1997 Feb; 45(2):159-64. PubMed ID: 9247038
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes.
Esparza I; Green R; Schreiber RD
J Immunol; 1983 Nov; 131(5):2117-21. PubMed ID: 6415160
[TBL] [Abstract][Full Text] [Related]
32. Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
Kohl S
J Immunol; 1990 Jan; 144(1):307-12. PubMed ID: 2153165
[TBL] [Abstract][Full Text] [Related]
33. Interferon-alpha, -beta, and -gamma augment the levels of rRNA precursors in peritoneal macrophages but not in macrophage cell lines and fibroblasts.
Radzioch D; Clayton M; Varesio L
J Immunol; 1987 Aug; 139(3):805-12. PubMed ID: 2439593
[TBL] [Abstract][Full Text] [Related]
34. Potent activation of mouse macrophages by recombinant interferon-gamma.
Varesio L; Blasi E; Thurman GB; Talmadge JE; Wiltrout RH; Herberman RB
Cancer Res; 1984 Oct; 44(10):4465-9. PubMed ID: 6432314
[TBL] [Abstract][Full Text] [Related]
35. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
Blasi E; Herberman RB; Varesio L
J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
[TBL] [Abstract][Full Text] [Related]
36. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
Toda M; Martuza RL; Kojima H; Rabkin SD
J Immunol; 1998 May; 160(9):4457-64. PubMed ID: 9574551
[TBL] [Abstract][Full Text] [Related]
37. Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: relationship to activation for macrophage tumoricidal function.
Hamilton TA; Jansen MM; Somers SD; Adams DO
J Cell Physiol; 1986 Jul; 128(1):9-17. PubMed ID: 3087999
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of NO production in macrophages by IL-13 is counteracted by Herpes simplex virus infection through tumor necrosis factor-alpha-induced activation of NK-kappa B.
Paludan SR; Ellermann-Eriksen S; Malmgaard L; Mogensen SC
Eur Cytokine Netw; 2000 Jun; 11(2):275-82. PubMed ID: 10903807
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
40. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Jun CD; Yoon HJ; Kim HM; Chung HT
Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
